Which members of Congress traded Johnson & Johnson JNJ recently?

The latest reported trades: Rep. Thomas Kean, partial sale on 08/27 (reported 09/12), Sen. John Boozman, partial sale on 08/20 (reported 09/11) and Sen. Tommy Tuberville, full sale on 24/10/29 (reported 08/05).

Stocks

Johnson & Johnson JNJ

Health care sectorNYSE

Close: $267.55; 09/29 close
Day change: −1.6%; vs previous close
Volume: 399,383; +2.5% vs 30-day average
52-week range: $179.85$280.63
1-year return: +47.3%; vs the close a year ago
Market cap: $644.8B; 2,409,898,597 shares · reported 07/17

Company

Exchange: NYSE
Sector: Health care
Industry: Pharmaceutical Preparations
Headquarters: New Brunswick, New Jersey
Fiscal year end: 01/03
Next earnings: 10/15, estimated

Members of Congress reported 10 trades in Johnson & Johnson JNJ in the past 90 days (3 purchases, 7 sales).

Korean holdings rank: Outside the top 50; Korea Securities Depository · released 09/22
Congress trades: 10; Last 90 days · 3 buys · 7 sales
Insider net buying: No record; Last 90 days · 0 buys · 0 sales
Next earnings: 10/15; Estimated from the last four quarters

Price

$267.55Day −1.6%1 year +47.3%

26-week trading

Common questions

Which members of Congress traded Johnson & Johnson JNJ recently?: The latest reported trades: Rep. Thomas Kean, partial sale on 08/27 (reported 09/12), Sen. John Boozman, partial sale on 08/20 (reported 09/11) and Sen. Tommy Tuberville, full sale on 24/10/29 (reported 08/05).